 Sophia Ambruso
Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperaldosteronism | 1 | 2022 | 8 | 0.790 |
Why?
| | Hypokalemia | 1 | 2022 | 23 | 0.780 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 637 | 0.780 |
Why?
| | Acute Lung Injury | 2 | 2021 | 268 | 0.720 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 428 | 0.630 |
Why?
| | Metabolome | 1 | 2021 | 274 | 0.600 |
Why?
| | Ischemia | 1 | 2021 | 361 | 0.590 |
Why?
| | Peritoneal Dialysis | 1 | 2018 | 84 | 0.570 |
Why?
| | Pneumonia | 1 | 2021 | 563 | 0.510 |
Why?
| | Oxidative Stress | 1 | 2021 | 1068 | 0.480 |
Why?
| | Hypertension | 2 | 2022 | 1052 | 0.480 |
Why?
| | Kidney Failure, Chronic | 1 | 2018 | 489 | 0.430 |
Why?
| | Glomerulonephritis, Membranoproliferative | 1 | 2022 | 13 | 0.200 |
Why?
| | Renin | 1 | 2022 | 31 | 0.200 |
Why?
| | Aldosterone | 1 | 2022 | 42 | 0.200 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 56 | 0.190 |
Why?
| | Syndrome | 1 | 2022 | 330 | 0.180 |
Why?
| | Piperidines | 1 | 2022 | 159 | 0.180 |
Why?
| | Adenine | 1 | 2022 | 218 | 0.180 |
Why?
| | Videoconferencing | 1 | 2020 | 57 | 0.170 |
Why?
| | Education, Distance | 1 | 2020 | 38 | 0.170 |
Why?
| | Dialysis Solutions | 1 | 2019 | 21 | 0.170 |
Why?
| | Kidney Diseases | 1 | 2022 | 349 | 0.160 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2019 | 26 | 0.160 |
Why?
| | Pulmonary Edema | 1 | 2019 | 109 | 0.150 |
Why?
| | Education, Medical, Undergraduate | 1 | 2020 | 160 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 366 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2021 | 727 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2019 | 414 | 0.120 |
Why?
| | Renal Dialysis | 1 | 2018 | 375 | 0.120 |
Why?
| | Quality Improvement | 1 | 2019 | 944 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4680 | 0.100 |
Why?
| | Cytokines | 1 | 2019 | 1824 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2019 | 2122 | 0.080 |
Why?
| | Quality of Life | 1 | 2018 | 2343 | 0.070 |
Why?
| | Humans | 7 | 2022 | 114045 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2022 | 677 | 0.060 |
Why?
| | Mice | 1 | 2021 | 14843 | 0.060 |
Why?
| | Male | 4 | 2022 | 55396 | 0.050 |
Why?
| | Proteinuria | 1 | 2022 | 77 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 68 | 0.050 |
Why?
| | Morale | 1 | 2020 | 5 | 0.040 |
Why?
| | Animals | 1 | 2021 | 31565 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 496 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2022 | 554 | 0.040 |
Why?
| | Hospitals, University | 1 | 2019 | 169 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2019 | 66 | 0.040 |
Why?
| | Propensity Score | 1 | 2019 | 225 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 714 | 0.040 |
Why?
| | Kidney | 1 | 2022 | 1182 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2019 | 773 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2019 | 614 | 0.030 |
Why?
| | Length of Stay | 1 | 2019 | 957 | 0.030 |
Why?
| | Critical Illness | 1 | 2019 | 640 | 0.030 |
Why?
| | Telemedicine | 1 | 2020 | 662 | 0.020 |
Why?
| | Aged | 2 | 2019 | 18969 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 6306 | 0.020 |
Why?
| | Stroke | 1 | 2019 | 1019 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 2958 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4090 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2349 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 26605 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2464 | 0.020 |
Why?
| | Female | 2 | 2019 | 59324 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 12521 | 0.010 |
Why?
| | Adult | 1 | 2019 | 30375 | 0.010 |
Why?
|
|
Ambruso's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|